FierceBiotech 2026年4月30日 Leo Pharma pays $50M for Replay and its preclinical skin disease gene therapy
FierceBiotech 2026年4月30日 BeOne signs $2B deal for option on preclinical trispecific antibody from China’s Huahui
FierceBiotech 2026年4月30日 Avalyn heads to Nasdaq with oversized $300M IPO to fund reformulated respiratory drugs
FierceBiotech 2026年4月29日 FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
FierceBiotech 2026年4月29日 Rising costs push GE HealthCare to cut outlook as it restructures units and leadership
FierceBiotech 2026年4月29日 GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program
FierceBiotech 2026年4月28日 FDA unveils plan for real-time review of clinical trial data, with AstraZeneca and Amgen already on board
FierceBiotech 2026年4月28日 FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting
FierceBiotech 2026年4月28日 Erasca hits ‘home run’ with cancer data as analyst suggests stock drop prompted by patient death
FierceBiotech 2026年4月28日 Incyte’s JAK inhibitor scores phase 3 vitiligo wins but can’t quite shake off Rinvoq
FierceBiotech 2026年4月28日 AbbVie dips into boiling RAS waters with $1.45B biobucks deal that could end in acquisition
FierceBiotech 2026年4月28日 Protagonist opts for $475M in Takeda payouts instead of splitting US rusfertide profits